Shaun Shadaker
Overview
Explore the profile of Shaun Shadaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Said S, Shadaker S, McMahon B, Armstrong P, Beckett G, Kamili S, et al.
J Viral Hepat
. 2024 Dec;
32(1):e14051.
PMID: 39707980
Zanzibar, a low-resource semiautonomous region of Tanzania, has an estimated prevalence of hepatitis B virus (HBV) infections of 3.6%. To assess the feasibility of care and treatment, a 5-year hepatitis...
2.
Shadaker S, Baliashvili D, Alkhazashvili M, Getia V, Tskhomelidze Schumacher I, Surguladze S, et al.
Transfus Clin Biol
. 2024 Nov;
32(1):39-43.
PMID: 39547544
Background And Objectives: Blood donor cohorts are an underappreciated resource for surveillance and public health programming for infectious diseases. The incidence of hepatitis C virus (HCV) infection was evaluated in...
3.
Zakalashvili M, Surguladze S, Baliashvili D, Zarkua J, Avalishvili T, Tsirdava E, et al.
J Viral Hepat
. 2024 Oct;
31(12):880-889.
PMID: 39387485
A nationwide serosurvey among adults in 2021 showed a 2.7% (95% confidence interval [CI]: 2.3%-3.4%) prevalence of hepatitis B. Our analysis evaluates knowledge, attitudes and practices (KAP) for hepatitis B...
4.
Surguladze S, Armstrong P, Beckett G, Shadaker S, Gamkrelidze A, Tsereteli M, et al.
BMC Infect Dis
. 2024 Sep;
24(1):1045.
PMID: 39333949
Background: Hepatitis C virus (HCV) infection can lead to a type of primary liver cancer called hepatocellular carcinoma (HCC). Georgia, a high HCV prevalence country, started an HCV elimination program...
5.
Butsashvili M, Kanchelashvili G, Aslanikashvili A, Kuchuloria T, Shadaker S, Tskhomelidze I, et al.
J Infect Prev
. 2024 Sep;
25(5):182-187.
PMID: 39318726
Background: Individuals receiving hemodialysis for end-stage kidney disease are at increased risk of infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) due to regular and frequent receipt...
6.
Tohme R, Shadaker S, Adamia E, Khonelidze I, Stvilia K, Getia V, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Aug;
73(30):660-666.
PMID: 39088368
Hepatitis B and hepatitis C are leading causes of cirrhosis and liver cancer and caused 1.3 million deaths worldwide in 2022. Hepatitis B is preventable with vaccination, and hepatitis C...
7.
Aniekwe C, Getia V, Gvinjilia L, Manders E, Shadaker S, Tskhomelidze Schumacher I, et al.
J Public Health Manag Pract
. 2024 Jul;
30(5):643-646.
PMID: 39041759
No abstract available.
8.
Handanagic S, Shadaker S, Drobeniuc J, Tsereteli M, Alkhazashvili M, Adesigbin C, et al.
J Infect Dis
. 2023 Sep;
229(Supplement_3):S334-S341.
PMID: 37739781
In 2016, the World Health Organization introduced global targets for the care and management of hepatitis C virus (HCV) infection to eliminate hepatitis C as a public health threat by...
9.
Walker J, Tskhomelidze I, Shadaker S, Tsereteli M, Handanagic S, Armstrong P, et al.
Euro Surveill
. 2023 Jul;
28(30).
PMID: 37498534
BackgroundBetween May 2015 and February 2022, 77,168 hepatitis C virus (HCV)-infected people in Georgia have been treated through an HCV elimination programme. To project the programme's long-term impacts, an HCV...
10.
Khetsuriani N, Gamkrelidze A, Shadaker S, Tsereteli M, Alkhazashvili M, Chitadze N, et al.
Euro Surveill
. 2023 Jul;
28(30).
PMID: 37498531
BackgroundGeorgia has adopted the World Health Organization European Region's and global goals to eliminate viral hepatitis. A nationwide serosurvey among adults in 2015 showed 2.9% prevalence for hepatitis B virus...